Molecular Genetics & Genomic Medicine (Nov 2022)

High‐level gonosomal mosaicism for a pathogenic non‐coding CNV deletion of the lung‐specific FOXF1 enhancer in an unaffected mother of an infant with ACDMPV

  • Esra Yıldız Bölükbaşı,
  • Justyna A. Karolak,
  • Przemyslaw Szafranski,
  • Tomasz Gambin,
  • Nicholas Willard,
  • Steven H. Abman,
  • Csaba Galambos,
  • John P. Kinsella,
  • Paweł Stankiewicz

DOI
https://doi.org/10.1002/mgg3.2062
Journal volume & issue
Vol. 10, no. 11
pp. n/a – n/a

Abstract

Read online

Abstract Background Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) results from haploinsufficiency of the mesenchymal transcription factor FOXF1 gene. To date, only one case of an ACDMPV‐causative CNV deletion inherited from a very‐low level somatic mosaic mother has been reported. Methods Clinical, histopathological, and molecular studies, including whole genome sequencing, chromosomal microarray analysis, qPCR, and Sanger sequencing, followed by in vitro fertilization (IVF) with preimplantation genetic testing (PGT) were used to study a family with a deceased neonate with ACDMPV. Results A pathogenic CNV deletion of the lung‐specific FOXF1 enhancer in the proband was found to be inherited from an unaffected mother, 36% mosaic for this deletion in her peripheral blood cells. The qPCR analyses of saliva, buccal cells, urine, nail, and hair samples revealed 19%, 18%, 15%, 19%, and 27% variant allele fraction, respectively, indicating a high recurrence risk. Grandparental studies revealed that the deletion arose on the mother's paternal chromosome 16. PGT studies revealed 44% embryos with the deletion, reflecting high‐level germline mosaicism. Conclusion Our data further demonstrate the importance of parental testing in ACDMPV families and reproductive usefulness of IVF with PGT in families with high‐level parental gonosomal mosaicism.

Keywords